Novyra Pharmachem Limited
BSE: BANSTEA · Tea & Coffee
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Novyra Pharmachem Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Bansisons Tea Industries Limited is an India-based company engaged in the processing and manufacturing of CTC tea. The company procures green tea leaves and processes them into various grades of black tea for the domestic market.
Business Model
The company generates revenue by procuring raw green tea leaves and converting them into processed black tea at its manufacturing facilities. It focuses on the regional tea market in North Bengal.
Growth Outlook
Growth is primarily tied to the regional demand for tea in North Bengal and the company's ability to manage production yields effectively.
Key Risks
- Climatic Dependency. The company's production yields are highly susceptible to regional weather patterns and seasonal variations.
- Commodity Price Volatility. Fluctuations in the market price of green tea leaves and processed black tea can significantly impact profit margins.
- Regional Concentration. Reliance on the North Bengal market limits geographical diversification and exposes the company to localized economic or supply chain disruptions.
Start your research today
Unlock AI insights, financials, peers and live data on Novyra Pharmachem Limited and 5,000+ companies — free.
Key Metrics
NET PROFIT
₹5 Cr
TTM · standalone
EPS
₹8.48
TTM · standalone
RETURN ON EQUITY
117.9%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
0.8%
TTM · standalone
P/E
1.3x
Q4 FY26 · standalone
EV/EBITDA
1.0x
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Tea & Coffee
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Novyra Pharmachem LimitedBANSTEA | ₹6 Cr | 1.26 | 1.05 | — | 4153.8% | 117.9% | 0.8% | — |
Tata Consumer Products Ltd.TATACONSUM | ₹98,400 Cr | 57.93 | 31.40 | 15.6% | 14.9% | 7.9% | 9.0% | -16.4% |
CCL Products (India) LimitedCCL | ₹13,930 Cr | 32.54 | 19.32 | 35.8% | 16.9% | 20.1% | 22.7% | +23.8% |
Andrew Yule & CoANDREWYU | ₹1,373 Cr | 33.31 | 21.29 | -4.8% | 23.5% | 11.1% | 16.7% | -4.5% |
Goodricke GroupGOODRICKE | ₹506 Cr | 7.45 | 7.33 | -7.5% | 8.3% | 22.0% | 16.8% | +15.8% |
Mcleod Russel India LimitedMCLEODRUSS | ₹493 Cr | -4.76 | 517.66 | — | 0.3% | 185.0% | -21.7% | +9.0% |
As of Q4 FY26
Financials
Novyra Pharmachem Limited
BSE: BANSTEA · Tea & Coffee
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Novyra Pharmachem Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Bansisons Tea Industries Limited is an India-based company engaged in the processing and manufacturing of CTC tea. The company procures green tea leaves and processes them into various grades of black tea for the domestic market.
Business Model
The company generates revenue by procuring raw green tea leaves and converting them into processed black tea at its manufacturing facilities. It focuses on the regional tea market in North Bengal.
Growth Outlook
Growth is primarily tied to the regional demand for tea in North Bengal and the company's ability to manage production yields effectively.
Key Risks
- Climatic Dependency. The company's production yields are highly susceptible to regional weather patterns and seasonal variations.
- Commodity Price Volatility. Fluctuations in the market price of green tea leaves and processed black tea can significantly impact profit margins.
- Regional Concentration. Reliance on the North Bengal market limits geographical diversification and exposes the company to localized economic or supply chain disruptions.
Start your research today
Unlock AI insights, financials, peers and live data on Novyra Pharmachem Limited and 5,000+ companies — free.
Key Metrics
NET PROFIT
₹5 Cr
TTM · standalone
EPS
₹8.48
TTM · standalone
RETURN ON EQUITY
117.9%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
0.8%
TTM · standalone
P/E
1.3x
Q4 FY26 · standalone
EV/EBITDA
1.0x
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Tea & Coffee
As of Q4 FY26